The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Medifast Inc

NYSE: MED
Last

(U.S.) $55.53

Today's change-0.10 -0.18%
Updated August 22 3:37 PM EDT. Delayed by at least 15 minutes.
 

Medifast Inc

NYSE: MED
Last

(U.S.) $55.53

Today's change-0.10 -0.18%
Updated August 22 3:37 PM EDT. Delayed by at least 15 minutes.

Reversal following new 52-week high

Medifast Inc is lower today, dropping (U.S.)$0.10 or 0.18% to (U.S.)$55.53 after setting a new 52-week high. Over the last five days, shares have gained 6.73% and are currently 1.69% off of the 52-week high. Shares have outperformed the S&P 500 by 38.75% during the last year.

Key company metrics

  • Open(U.S.) $55.66
  • Previous close(U.S.) $55.63
  • High(U.S.) $56.11
  • Low(U.S.) $55.27
  • Bid / Ask(U.S.) $55.49 / (U.S.) $55.57
  • YTD % change+33.39%
  • Volume120,409
  • Average volume (10-day)211,937
  • Average volume (1-month)125,374
  • Average volume (3-month)90,669
  • 52-week range(U.S.) $35.55 to (U.S.) $56.49
  • Beta0.30
  • Trailing P/E27.88×
  • P/E 1 year forward26.24×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $1.28
  • Dividend yield2.31%
  • Trailing EPS(U.S.) $1.99
Updated August 22 3:37 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+8.62%

Based on its net profit margin of 8.62%, Medifast Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.29%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Food Processing

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue76716269
Total other revenue--------
Total revenue76716269
Gross profit58534752
Total cost of revenue18181516
Total operating expense64625660
Selling / general / administrative46444043
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income11979
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax11979
Income after tax8646
Income tax, total4333
Net income8646
Total adjustments to net income--------
Net income before extra. items8646
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items8646
Inc. avail. to common incl. extra. items8646
Diluted net income8646
Dilution adjustment0------
Diluted weighted average shares12121212
Diluted EPS excluding extraordinary itemsvalue per share0.630.510.340.51
Dividends per sharevalue per share0.320.320.320.25
Diluted normalized EPSvalue per share0.630.510.340.51